The present invention concerns the use of protein biomarkers for use in facilitating in the prognosis and/or treatment regime of bladder cancer. In particular, the invention relates to the use of shed protein fragments, such as fragments of Epithelial cell adhesion molecule (EpCAM) and/or ...
Tumour immune regulation has attracted widespread attention, and long noncoding RNAs (lncRNAs) play an important role in this process. Therefore, we evaluated patient prognosis by exploring the relationship between bladder cancer (BLCA) and immune-relate
et al. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy. Eur. Urol. 66, 1157–1164 (2014). Initial large study demonstrating ...
The present study analyzed the survival rate in patients with stage T2-T3a bladder cancer who had been treated by radical cystectomy. The records of 50 patients with T2-T3a NO tumor, submitted to pelvic lymphadenectomy and radical cystoprostatectomy, were reviewed to determine the prognosis in ...
Prognostic factors according to tumor stage, mitotic count, and tumor grade can, to some extent, predict biologic tumor behavior and prognosis. The role of postoperative radiation therapy and adjuvant progestogens, particularly for low-... M F. C.,A C.,S D. - 《Am J Cancer》 被引量: ...
Urothelial cancer staged as T1G3 presents urologist with challenges, because it has poor outcome if treated as superficial bladder tumor. Transurethral resection is the standard treatment for the non-muscle-invasive bladder tumor. However, high-grade T1 bladder tumor has potentially ...
Surgical treatment of bladder cancer (1) operation The scope and method of specific surgery should be determined according to the stage of the tumor, the degree of malignancy, the pathological type, the size and location of the tumor, the presence of adjacent organs and so on. Different surgic...
Immunohistochemical staining of CA 50antigen in human bladder cancer: Relation to histologic grade, clinical stage, and prognosis Immunohistochemical staining of CA 50antigen in human bladder cancer: Relation to histologic grade, clinical stage, and prognosis PKLJE Collan - 《Urology》 被引量: 6发表...
the prognosis is not good due to high recurrence rates. Once metastasized, the 5-year survival rate is only about 6% [2]. Cisplatin-based chemotherapy is still the standard of care in managing advanced bladder cancer, with a disappointing median overall survival of 13.1 months [3]. Meanwhile...
Gallbladder cancer Gallbladder cancer is the most common cancer of the biliary tract and often has a very poor prognosis. This Primer by Roa and colleagues summarizes the epidemiology, mechanisms, diagnosis and treatment of gallbladder cancer, and discusses patient quality of life and open researc...